公司资料
Avinger 股价、新闻与催化剂
- 股票代码:
- AVGR
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for AVGR.
公司概览
业务概览
Avinger is a medical device company focused on image-guided vascular intervention systems. Its business is centered on procedure-linked devices used to treat peripheral artery disease and related vascular conditions.
所在地与行业分类
Avinger is headquartered in the United States and listed on NASDAQ. It sits in vascular medtech rather than biotechnology.
商业模式特征
The company depends on device adoption, hospital or physician training, and the ability to scale procedure-based sales. Investors watch product clearance, commercialization, and operating execution.
生物医药行业定位
Avinger belongs in the vascular-device layer of healthcare. It is not biotech, but its stock is driven by procedural adoption and product execution.
未来催化剂
- Avinger’s catalysts are image-guided atherectomy adoption and any commercialization update that shows the device can keep finding a durable clinical niche. The company needs recurring procedural use to matter.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。